Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA)

a meta-analysis of 28 studies

Nicholas Zaorsky, Eric J. Lehrer, Gargi Kothari, Alexander V. Louie, Shankar Siva

Research output: Contribution to journalReview article

Abstract

Stereotactic radiotherapy is safe and efficacious in the management of extracranial and intracranial renal cell oligometastases, with local control at 90% and any significant toxicity at 1%.

Original languageEnglish (US)
JournalEuropean Urology Oncology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Renal Cell Carcinoma
Meta-Analysis
Radiotherapy
Kidney

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Surgery
  • Oncology
  • Urology

Cite this

@article{582d6051805f4e0eb9b876736ed868a2,
title = "Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies",
abstract = "Stereotactic radiotherapy is safe and efficacious in the management of extracranial and intracranial renal cell oligometastases, with local control at 90{\%} and any significant toxicity at 1{\%}.",
author = "Nicholas Zaorsky and Lehrer, {Eric J.} and Gargi Kothari and Louie, {Alexander V.} and Shankar Siva",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.euo.2019.05.007",
language = "English (US)",
journal = "European Urology Oncology",
issn = "2588-9311",

}

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA) : a meta-analysis of 28 studies. / Zaorsky, Nicholas; Lehrer, Eric J.; Kothari, Gargi; Louie, Alexander V.; Siva, Shankar.

In: European Urology Oncology, 01.01.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA)

T2 - a meta-analysis of 28 studies

AU - Zaorsky, Nicholas

AU - Lehrer, Eric J.

AU - Kothari, Gargi

AU - Louie, Alexander V.

AU - Siva, Shankar

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Stereotactic radiotherapy is safe and efficacious in the management of extracranial and intracranial renal cell oligometastases, with local control at 90% and any significant toxicity at 1%.

AB - Stereotactic radiotherapy is safe and efficacious in the management of extracranial and intracranial renal cell oligometastases, with local control at 90% and any significant toxicity at 1%.

UR - http://www.scopus.com/inward/record.url?scp=85068514704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068514704&partnerID=8YFLogxK

U2 - 10.1016/j.euo.2019.05.007

DO - 10.1016/j.euo.2019.05.007

M3 - Review article

JO - European Urology Oncology

JF - European Urology Oncology

SN - 2588-9311

ER -